Ugo Basile’s Contribution to Preclinical Research: Advancing Solutions for Schizophrenia
24th May marks the World Awarness Day on Schizophrenia, a chronic and severe mental disorder that affects around 24 million people worldwide.
Ugo Basile offers a range of sophisticated tools designed to facilitate preclinical studies on schizophrenia.